Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 3737 - 3744 of 12089 results
Energy & Sustainability Event Highlights — October 2020
October 5, 2020| Article| Viewpoint
NYSE Further Extends Waiver of Certain Shareholder Approval Requirements as a Result of Coronavirus (COVID-19)
October 2, 2020| Advisory| Viewpoint
This is Big: Visa Pathway Opens for Foreign Workers Seeking H-1B; H-2B; L-1 and J-1 Visa Stamps
October 2, 2020| Blog| Viewpoint
MintzTech Connect: All Things Technology — October 2020
October 1, 2020| Article| Viewpoint
Peabody and Arch Walk Away from Joint Venture After District Court Grants FTC’s Request for Preliminary Injunction
October 1, 2020| Alert| Viewpoint
California Update: Governor Signs One Privacy Bill and Vetoes Another
October 1, 2020| Blog| Viewpoint
As Election Nears, Mintz Attorney Discusses Biden's Tax Incentives Proposal
October 1, 2020| News
How Do You Make Your Workplace Culture Into One That Will Be Embraced?
October 1, 2020| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|